长风药业股份有限公司

Chinese specialty pharmaceutical company focused on pulmonary and other drug delivery technologies, serving both Chinese and international markets. Offers integrated management of respiratory disease across allergic rhinitis, asthma, chronic obstructive pulmonary disease, respiratory infection, pulmonary fibrosis and pulmonary hypertension. Runs its own research through commercial production system with core capabilities in drug particle engineering and characterisation, formulation quality evaluation, in vitro-in vivo correlation, process optimisation and scale-up, delivery device design and liposomal delivery, and a pipeline spanning inhalation aerosols, dry powder inhalers, inhalation solutions, inhalation sprays, nasal sprays and liposomes. Named to a Chinese unicorn incubation list and has begun exporting its inhalation products.